Detail akcie Bio-Techne online

Business Summary: Bio-Techne Corporation is a global life sciences company providing tools and bioactive reagents for the research and clinical diagnostic communities. The Company's products assist scientific investigations into biological processes and the nature and progress of specific diseases. The Company, in partnership with Wilson Wolf, is creating products such as media and cytokines that are specifically tailored to G-Rex Bioreactors. Its segments include Protein Sciences and Diagnostics and Genomics. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, and tissue biopsy analysis.
Financial Summary: BRIEF: For the nine months ended 31 March 2025, BIO-TECHNE Corp revenues increased 6% to $902.7M. Net income applicable to common stockholders decreased 29% to $91.1M. Revenues reflect Protein Sciences segment increase of 56% to $643.8M, Diagnostics and Genomics segment increase of 57% to $256.6M, Other revenue segment increase of 98% to $4.2M, United States segment increase of 58% to $506.8M, U.K segment increase of 59% to $196M.